Found 6 matching trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
PHASE3The purpose of this study is to evaluate the efficacy of gevokizumab in red...
Location
Multiple Locations
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
PHASE3The purpose of this study is to evaluate the efficacy of gevokizumab in the...
Location
Multiple Locations
Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus
PHASE1The purpose of this study is to evaluate the safety and pharmacokinetics (P...
Location
Multiple Locations
Single-dose, Dose-escalation Study of Safety, PK, and Preliminary Efficacy of XOMA 052 in Type 2 Diabetes Mellitus
PHASE1The purpose of this study is to evaluate the safety, pharmacokinetics (PK) ...
Location
Covance Clinical Research (formerly Swiss Pharma Contract)
Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis
PHASE2Study X052070 will evaluate the safety and pharmacokinetics (PK) of XOMA 05...
Location
Multiple Locations
Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD™-B)
PHASE3The objective of this study is to demonstrate the superiority of gevokizuma...
Location
Yonsei University Severance Hospital